Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2013766rdf:typepubmed:Citationlld:pubmed
pubmed-article:2013766lifeskim:mentionsumls-concept:C0020792lld:lifeskim
pubmed-article:2013766lifeskim:mentionsumls-concept:C1512035lld:lifeskim
pubmed-article:2013766lifeskim:mentionsumls-concept:C0038590lld:lifeskim
pubmed-article:2013766lifeskim:mentionsumls-concept:C0027930lld:lifeskim
pubmed-article:2013766lifeskim:mentionsumls-concept:C2263240lld:lifeskim
pubmed-article:2013766lifeskim:mentionsumls-concept:C0205266lld:lifeskim
pubmed-article:2013766pubmed:issue5lld:pubmed
pubmed-article:2013766pubmed:dateCreated1991-5-16lld:pubmed
pubmed-article:2013766pubmed:abstractTextTwo hours after the injection of (3-[125I]iodotyrosyl3) neurotensin into the striatum, a labeling was observed in the ipsilateral substantia nigra. In the present study, we demonstrated by HPLC that this radioactivity corresponded to intact neurotensin and to degradation products of this peptide. This finding provides the first clearcut evidence that a neuropeptide can be internalized and retrogradely transported in brain neurons. Therefore, the fact that intact neurotensin can be seen to exist over a long period of time in the cell body suggests that the retrograde transport process could perhaps be involved in the long-term effects of neuropeptides.lld:pubmed
pubmed-article:2013766pubmed:languageenglld:pubmed
pubmed-article:2013766pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2013766pubmed:citationSubsetIMlld:pubmed
pubmed-article:2013766pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2013766pubmed:statusMEDLINElld:pubmed
pubmed-article:2013766pubmed:monthMaylld:pubmed
pubmed-article:2013766pubmed:issn0022-3042lld:pubmed
pubmed-article:2013766pubmed:authorpubmed-author:BoireauAAlld:pubmed
pubmed-article:2013766pubmed:authorpubmed-author:LaduronP MPMlld:pubmed
pubmed-article:2013766pubmed:authorpubmed-author:FaucherDDlld:pubmed
pubmed-article:2013766pubmed:authorpubmed-author:CastelM NMNlld:pubmed
pubmed-article:2013766pubmed:authorpubmed-author:CuinéFFlld:pubmed
pubmed-article:2013766pubmed:authorpubmed-author:DubédatPPlld:pubmed
pubmed-article:2013766pubmed:issnTypePrintlld:pubmed
pubmed-article:2013766pubmed:volume56lld:pubmed
pubmed-article:2013766pubmed:ownerNLMlld:pubmed
pubmed-article:2013766pubmed:authorsCompleteYlld:pubmed
pubmed-article:2013766pubmed:pagination1816-8lld:pubmed
pubmed-article:2013766pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:2013766pubmed:meshHeadingpubmed-meshheading:2013766-...lld:pubmed
pubmed-article:2013766pubmed:meshHeadingpubmed-meshheading:2013766-...lld:pubmed
pubmed-article:2013766pubmed:meshHeadingpubmed-meshheading:2013766-...lld:pubmed
pubmed-article:2013766pubmed:meshHeadingpubmed-meshheading:2013766-...lld:pubmed
pubmed-article:2013766pubmed:meshHeadingpubmed-meshheading:2013766-...lld:pubmed
pubmed-article:2013766pubmed:meshHeadingpubmed-meshheading:2013766-...lld:pubmed
pubmed-article:2013766pubmed:meshHeadingpubmed-meshheading:2013766-...lld:pubmed
pubmed-article:2013766pubmed:meshHeadingpubmed-meshheading:2013766-...lld:pubmed
pubmed-article:2013766pubmed:meshHeadingpubmed-meshheading:2013766-...lld:pubmed
pubmed-article:2013766pubmed:meshHeadingpubmed-meshheading:2013766-...lld:pubmed
pubmed-article:2013766pubmed:meshHeadingpubmed-meshheading:2013766-...lld:pubmed
pubmed-article:2013766pubmed:year1991lld:pubmed
pubmed-article:2013766pubmed:articleTitleIdentification of intact neurotensin in the substantia nigra after its retrograde axonal transport in dopaminergic neurons.lld:pubmed
pubmed-article:2013766pubmed:affiliationRhône-Poulenc Rorer, Centre de Recherches de Vitry-Alfortville, Vitry-sur-Seine, France.lld:pubmed
pubmed-article:2013766pubmed:publicationTypeJournal Articlelld:pubmed